摘要骨骼肌松弛药是临床麻醉中的一类常用药物，全身麻醉手术中合理应用骨骼肌松弛药和神经肌肉阻滞拮抗药，及时进行神经肌肉阻滞监测，能为患者提供有效的安全保障。近年来，关于骨骼肌松弛药、神经肌肉阻滞拮抗药、新型神经肌肉阻滞监测设备等的研究内容不断扩充更新。本文参考国内外最新文献，基于骨骼肌松弛药临床应用实践经验和研究前沿，从术中应用、监测和术后拮抗等方面介绍了骨骼肌松弛药的应用规范和管理策略，并在专家组间初步达成共识。本共识的制定旨在为骨骼肌松弛药的临床应用提供指导性意见，便于临床医师参阅，同时欢迎读者提出相关意见和建议，以便进一步更新。

abstractsNeuromuscular blocking agents are one of the most commonly used drugs in clinical anesthesia. Reasonable applications of neuromuscular blocking agents and neuromuscular blockade antagonists, along with timely monitoring of neuromuscular blockade can provide safeguard for patients during surgery with general anesthesia. In recent years, the research on neuromuscular blocking agents, neuromuscular blockade antagonists, and new neuromuscular blockade monitoring devices has been continuously updated. By referring to the latest domestic and international literature, and based on the practical experience as well as the research frontier of neuromuscular blocking agents, this paper introduces the application standards and management strategies of neuromuscular blocking agents from the aspects of intraoperative application, monitoring, and postoperative antagonism, which has reached a consensus among expert groups ultimately.The formulation of this consensus aims to provide instructional proposals for the clinical application of neuromuscular blocking agents for clinicians to refer to. Readers are welcome to put forward relevant opinions and suggestions for further updates.